FDA Investigator Barbara J Holladay
Barbara J Holladay has conducted inspections on 117 sites in 1 countries as of 15 Jun 2004. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
117
Last Inspection Date:
15 Jun 2004
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Barbara J Holladay:
Abdellah El Hajjam,
Addie V Scott Boston,
Adriana N Jimenez Lopez,
Amber G Chung,
Amy A Johnson,
Amy C Amaro,
Ana P Barido,
Andrea S Heise,
Andrew J Gonzales,
Andrew J Howard,
Anthony W Lee,
Antoine El Hage, PhD,
Ashley M Whitehurst,
Austin B Appler,
Barbara A Burke,
Barbara A Gullick,
Barbara Janine Breithaupt,
Billingsley,
Brandon J Brookens,
Brandon L Mariner,
Brian M Palermo,
Brian R Yaun,
Brooke K Higgins,
Bruce C Kovak,
Bryan J Love,
Byungja E Marciante,
Carl E Lovrich,
Carla C Tuite,
Carol Rivera Lopez, PhD,
Carrie L Doupnik,
Catherine Whiteside, PhD,
Cecil D Mitchell,
Chaltu Nwakijra,
Charlean R Butler,
Charles D Boison,
Charles E Idjagboro,
Charles M Kerns, BLT DO,
Charles R Bonapace, PhD,
Christian D Lynch (CDL),
Christine M Whitby, CSO,
Clarice J Ahn,
Collins M Mason,
Cynthia A Harris, MD, RN,
Cynthia Jim, CSO,
Daniel R Azar,
Danielle R Rainey,
David K Glasgow,
David L Chon,
David P Rice, Jr,
Debra Bower,
Debra D Devlieger,
Denise R Beuttenmuller,
Dennis L Doupnik,
Dianne H Milazzo,
Douglas A Campbell,
Dr. Abhijit Raha, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dung N Tran,
Dylan D Yao, MD, PhD,
Earl Echon,
Elvis D Morton,
Emest F Bizjak,
Emmanuel A Dimaano, Jr,
Erin L Mcfiren,
Erin M Mcdowell,
Esaw,
Gail L Katz,
Gajendiran Mahadevan, PhD,
Gale L Glinecki,
Gerald Mierle,
Gregory A Cronce,
Greta L Budweg,
Hector Jcolon Torres,
Holly S Simms,
Hugh M Mcclure, II,
Jacqueline A O'shaughnessy, PhD,
Jacqueline Johnson,
Jacqueline Mdiaz Albertini,
James F Mccormack, PhD,
James T Mccoy,
Jamie D Richardson,
Jamie D Swann,
Janete F Guardia,
Jeanne F Broderick,
Jeffrey A Reed,
Jeffrey A Sincek,
Jessica D Nanini,
Jessica D Weber,
Joell A Eifert,
John Dan,
John J Welsh, PhD,
John Kadavil, PhD,
John M Gusto,
Johnson,
Joseph W Matthews,
Julie D Bringger,
Justin A Hefferman,
Justin C Fuller,
Jyoti B Patel, PhD,
Karen A Spencer,
Kenneth L Smalls,
Kenneth Nieves,
Kimberley A Hoefen,
Kurt A Brorson, PhD,
La Tasham Gunter,
Lakisha M Williams,
Laurianne M Montonye,
Laurissa S Flowers,
Lawrence J Stringer,
LCDR Anastasia M Piliafas Brown,
LCDR Cornelius Brown, III,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Linda J Eason,
Linda S Mattingly,
Lori A Holmquist,
Lorraine L Chavis,
LT Melanie M Mayor, USPHS,
Lynette P Salisbury,
Marc A Jackson, Jr,
Margaret H Waters,
Marie B Buen Bigornia,
Marilyn M White,
Marion W Nadeau,
Melissa J Garcia,
Michael D Ellison,
Michael F Skelly, PhD,
Mildred L Mccray,
Mohamad A Chahine,
Nancy L Meade,
Nash,
Nebil A Oumer,
Nisha C Patel,
Norman K Starks,
Normica G Facey,
Nutan Mytle,
Osama M Hamoud,
Oumou Barry,
Patricia A Morrow,
Paula J Bretz,
Pelekakis,
Peter R Lenahan,
Philip J Snoy,
Rachel C Harrington,
Raymond W Niles,
Regina Gibson Melton,
Renisha M Shaw,
Richard Heath Coats,
Rina Bhikha,
Robert L Hummel,
Ronald T Nowalk,
Rose Ashley,
Ruark Lanham,
Sam H Haidar, PhD,
Sherry L Secrist, BLT DO,
Shusheen A Alexander,
Stacey A Priest,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Stephen C Eason,
Steven J Thurber,
Steven P Donald,
Susan J Essenmacher,
Susan M Jackson,
Sylvia R Dooling,
Tamara N Champion,
Tamika E Allen, RN,
Tania E Vizcaino,
Teresa L Fox,
Theresa M Smedley,
Thomas J Hudson,
Timothy M Albright,
Toyin B Oladimeji,
Tracy L Taras, PhD,
Valeria A Moore,
Victoria V Bot,
Wanda Y Honeyblue,
Wayne L Jefferson,
William A Warnick,
William D Bassett, Jr,
William D Murray,
Willy A Orantes,
Xiaohan Cai, PhD,
Xikui Chen (nmi), PhD,
Zachary L Miller,
Zhongren Wu
Barbara J Holladay's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2001 | FDA 483 Response | BioReliance Corporation - Form 483R, 2001-07-05 |
| December, 2002 | EIR | Ani Lytics, Inc. - EIR, 2002-12-03 |
| August, 2003 | FDA 483 | Douglas R Rosing MD - Form 483, 2003-08-08 |
| August, 2003 | EIR | Douglas R Rosing MD - EIR, 2003-08-08 |
| November, 2001 | EIR | Adam F. Lowy, M.D. - EIR, 2001-11-20 |
| June, 2001 | FDA 483 | BioReliance Corporation - Form 483, 2001-06-22 |
| July, 2003 | EIR | BioReliance Corporation - EIR, 2004-02-12 |
| May, 2003 | FDA 483 | Armed Forces Institute of Pathology - Form 483, 2003-05-12 |
| June, 2001 | EIR | BioReliance Corporation - EIR, 2001-06-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more